Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07573657Not Yet Recruiting

Ultrasound-Guided Core Needle Biopsy to Assess Sensitivity and Specificity of Axillary Lymph Node Metastasis in Breast Cancer

Role: collaborator

NCT07077343Not ApplicableRecruiting

AI-Guided Hematoma Aspiration vs. Conservative Treatment for Spontaneous ICH

Role: collaborator

NCT03024164Recruiting

Stroke Registration of Young Adults in China

Role: collaborator

NCT02811614Not ApplicableCompleted

Minimally-invasive Surgery Versus Craniotomy in Patients With Supratentorial Hypertensive Intracerebral Hemorrhage

Role: collaborator

NCT04451967Unknown

Acute Myocardial Infarction Study in Northeastern China

Role: collaborator

NCT03108716Not ApplicableCompleted

Hamate Hook Removal, Microscrew Internal Fixation and Plaster Fixation for the Treatment of Hamate Hook Fractures

Role: lead

All 6 trials loaded